Olanib 150 mg (Olaparib)

shared a link

2024-12-30 07:05:57 - Translate -

Olapar is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
#Olanib #Olaparib150mg #IebPharma #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-150-mg-olaparib

Olapar is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. #Olanib #Olaparib150mg #IebPharma #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-150-mg-olaparib

IEBPHARMA.COM

Olanib 150 mg (Olaparib)

Olanib 150 mg Olaparib is an anti-cancer medication primarily used to treat ovarian, breast, pancreatic, and prostate cancer.

0 Comments 0 Shares 106 Views 0 Reviews